Follow a representative sample of Latin American patients diagnosed with atrial fibrillation to set data on demographic characteristics, documenting antithrombotic therapy, describe the INR control level of VKA users, discontinuation rates and clinical outcomes, such as stroke, hemorrhage and death
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
INR control rate
Timeframe: 12 months
Oral anticoagulation discontinuation rate
Timeframe: 12 months
Percentage of death
Timeframe: 12 months
Percentage of stroke
Timeframe: 12 months
Percentage of systemic embolism
Timeframe: 12 months
Percentage of myocardial infarction
Timeframe: 12 months
Percentage of major bleeding
Timeframe: 12 months
Percentage of electrical cardioversion
Timeframe: 12 months
Percentage of percutaneous ablation of AF
Timeframe: 12 months
Percentage of atrioventricular junction ablation
Timeframe: 12 months
Percentage of patients that need of pacemaker implantation
Timeframe: 12 monts
Percentage of other cardiovascular hospitalization
Timeframe: 12 months